Literature DB >> 958514

Factors responsible for reduced pharmacological activity in rats of pentetrazol administered orally.

H W Vohland, H Zufelde.   

Abstract

It was the aim of this investigation to find out why pentetrazol (PTZ) administered orally to rats has considerably lower convulsive effectiveness than PTZ injected parenterally. It could be demonstrated that PTZ is distributed to and eliminated from all organs analyzed, without any sign of storage or of redistribution. Biological halftime was found to be about 3.5 h after subcutaneous injection. PTZ is absorbed slowly from the gastrointestinal tract because PTZ given orally is retained in the stomach for many hours. PTZ absorption is slow from the stomach while it is rapid from the small intestine. Food taken in before and after PTZ administration decreases the rate of PTZ absorption. Retention in the stomach of PTZ given orally is probably due to delayed gastric emptying since PTZ is able to reduce the basal tone and the acetylcholine-induced contractions of isolated preparations of the fundus of the stomach.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 958514     DOI: 10.1007/BF00507350

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  The diurnal course of water and food intake in the normal mature rat.

Authors:  P S SIEGEL; H L STUCKEY
Journal:  J Comp Physiol Psychol       Date:  1947-10

2.  [Metabolism of pentetrazole in the rat: isolation and identification of the main metabolites from urine (author's transl)].

Authors:  H W Vohland; P E Schulze; W Koransky; G Schulz; B Acksteiner
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1974-10

3.  Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function.

Authors:  J Leckman; J V Ananth; T A Ban; H E Lehmann
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Jul-Aug

Review 4.  Present understanding of the interaction of drugs and food during absorption.

Authors:  A Krondl
Journal:  Can Med Assoc J       Date:  1970-08-15       Impact factor: 8.262

5.  Circadian and estrual rhythms in food intake in the rat.

Authors:  M B ter Haar
Journal:  Horm Behav       Date:  1972-09       Impact factor: 3.587

6.  Biological disposition of pentylenetetrazol-10- 14 C in rats and humans.

Authors:  S G Rowles; G S Born; H T Russell; W V Kessler; J E Christian
Journal:  J Pharm Sci       Date:  1971-05       Impact factor: 3.534

7.  Variations in food and water intake in the normal and acyclic female rat.

Authors:  M F Tarttelin; R A Gorski
Journal:  Physiol Behav       Date:  1971-12

8.  [Biologic normal values in Wistar (Jena) rats of different ages. VI. Stomach emptying time, small intestine transit time and length development of the small intestine].

Authors:  H Hoffmann
Journal:  Z Versuchstierkd       Date:  1970

9.  A controlled study of the efficacy of pentylenetetrazol (Metrazol) with hard-core hospitalized psychogeriatric patients.

Authors:  B A Stotsky; J O Cole; L M Lu; C M Sniffin
Journal:  Am J Psychiatry       Date:  1972-10       Impact factor: 18.112

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  3 in total

1.  [On the toxicology of carbromal. II. Pharmacokinetics of carbromal and its hypnotically active metabolites in the rat (author's transl)].

Authors:  H W Vohland; S Hadisoemarto; B Wanke
Journal:  Arch Toxicol       Date:  1977-08-09       Impact factor: 5.153

2.  Seizure Susceptibility and Sleep Disturbance as Biomarkers of Epileptogenesis after Experimental TBI.

Authors:  Pedro Andrade; Leonardo Lara-Valderrábano; Eppu Manninen; Robert Ciszek; Jesse Tapiala; Xavier Ekolle Ndode-Ekane; Asla Pitkänen
Journal:  Biomedicines       Date:  2022-05-14

3.  Repeated administration of subconvulsant doses of GABA antagonist drugs. II. Effect on monoamine-mediated behaviour.

Authors:  P J Cowen; D J Nutt; C C Batts; A R Green; D J Heal
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.